Same Indication

Ipilimumab vs Trifarotene

Ipilimumab vs Trifarotene: Overview

This comparison examines the pharmacological differences between Ipilimumab and Trifarotene.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days.

Chemical Properties

Type: Ipilimumab — Antibody; Trifarotene — Small molecule.